🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested
The Bacille Calmette-Guérin (BCG) vaccine is the only vaccine licenced to p...
Status
Completed
Location
University of Oxford, Oxford Vaccine Group
Start Date
2014-06-20
Trial ID
NCT02002156
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this study is to evaluate the safety of Sabin Inactivated Po...
Status
Completed
Location
Gaoan Center for Disease Control and Prevention
Start Date
2022-06-13
Trial ID
NCT05432141
Treatments Being Tested
The general objectives of the proposed research work are: A1) to reduce ch...
Status
Completed
Location
Bandim Health Project
Start Date
1995-03
Trial ID
NCT00168662
Treatments Being Tested
Participants will receive vaccination for measles, mumps, and rubella (MMR)...
Status
Completed
Location
Zambia Emory HIV Research Project
Start Date
2015-08
Trial ID
NCT02589678
Treatments Being Tested
This study evaluated the antibody persistence of Chinese children five year...
Status
Not Yet Recruiting
Location
Si County Center for Disease Control and Prevention
Start Date
2026-01-30
Trial ID
NCT07338851
Primary Objective: 1. To describe the vaccine seroprotection (antibody tit...
Status
Completed
Location
Investigational Site Number :4840001
Start Date
2018-10-17
Trial ID
NCT03630705
Treatments Being Tested